Is there anything new in Pneumocystis jirovecii pneumonia?: Changes in P-jirovecii pneumonia over the course of the AIDS epidemic

被引：16

作者：

Morris, Alison ^{[1
]}

机构：

[1] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2008年 / 46卷 / 04期

关键词：

D O I：

10.1086/526779

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：634 / 636

页数：3

共 9 条

[1] A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era [J].

Arozullah, AM ;

Yarnold, PR ;

Weinstein, RA ;

Nwadiaro, N ;

McIlraith, TB ;

Chmiel, JS ;

Sipler, AM ;

Chan, CL ;

Goetz, MB ;

Schwartz, DN ;

Bennett, CL .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1081-1086

[2] Hospital service interventions and improving survival of AIDS patients St Mary's Hospital, London, 1982-1991 [J].

Beck, EJ ;

Mandalia, S ;

Miller, DL ;

Harris, JRW .

INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (05) :280-290

[3] EQUAL SURVIVAL RATES FOR 1ST, 2ND, AND 3RD EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

DOHN, MN ;

BAUGHMAN, RP ;

VIGDORTH, EM ;

FRAME, DL .

ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (12) :2465-2470

[4] CHANGES IN SURVIVAL OVER TIME AFTER A FIRST EPISODE OF PNEUMOCYSTIS-CARINII PNEUMONIA FOR EUROPEAN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

LUNDGREN, JD ;

BARTON, SE ;

KATLAMA, C ;

LEDERGERBER, B ;

GONZALEZLAHOZ, J ;

PINCHING, AJ ;

PROENCA, R ;

HEMMER, R ;

PEDERSEN, C ;

PHILLIPS, AN .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (08) :822-828

[5] Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy [J].

Miller, R. F. ;

Allen, E. ;

Copas, A. ;

Singer, M. ;

Edwards, S. G. .

THORAX, 2006, 61 (08) :716-721

[6] Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia [J].

Morris, A ;

Wachter, RM ;

Luce, J ;

Turner, J ;

Huang, L .

AIDS, 2003, 17 (01) :73-80

[7] Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States:: 1994-2003 [J].

Teshale, Eyasu H. ;

Hanson, Debra L. ;

Wolfe, Mitchell I. ;

Brooks, John T. ;

Kaplan, Jonathan E. ;

Bort, Zuleika ;

Sullivan, Patrick S. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (06) :879-883

[8] US hospital care for patients with HIV infection and pneumonia - The role of public, private, and veterans affairs hospitals in the early highly active antiretroviral therapy era [J].

Uphold, CR ;

Deloria-Knoll, M ;

Palella, FJ ;

Parada, JP ;

Chmiel, JS ;

Phan, L ;

Bennett, CL .

CHEST, 2004, 125 (02) :548-556

[9] Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients:: 1985-2006 [J].

Walzer, Peter D. ;

Evans, Hannah E. R. ;

Copas, Andrew J. ;

Edwards, Simon G. ;

Grant, Alison D. ;

Miller, Robert F. .

CLINICAL INFECTIOUS DISEASES, 2008, 46 (04) :625-633

← 1 →